| Literature DB >> 23698052 |
Milena Brasca1, Stefano Morandi, Tiziana Silvetti, Veronica Rosi, Stefano Cattaneo, Luisa Pellegrino.
Abstract
Hen egg-white lysozyme (LSZ) is currently used in the food industry to limit the proliferation of lactic acid bacteria spoilage in the production of wine and beer, and to inhibit butyric acid fermentation in hard and extra hard cheeses (late blowing) caused by the outgrowth of clostridial spores. The aim of this work was to evaluate how the enzyme activity in commercial preparations correlates to the enzyme concentration and can be affected by the presence of process-related impurities. Different analytical approaches, including turbidimetric assay, SDS-PAGE and HPLC were used to analyse 17 commercial preparations of LSZ marketed in different countries. The HPLC method adopted by ISO allowed the true LSZ concentration to be determined with accuracy. The turbidimetric assay was the most suitable method to evaluate LSZ activity, whereas SDS-PAGE allowed the presence of other egg proteins, which are potential allergens, to be detected. The analytical results showed that the purity of commercially available enzyme preparations can vary significantly, and evidenced the effectiveness of combining different analytical approaches in this type of control.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23698052 PMCID: PMC6269954 DOI: 10.3390/molecules18056008
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Origin, type, and composition characteristics of the commercial lysozyme preparations. Values not complying with specifications of EU Reg. 231/2012 are in bold.
| Sample | Country of Purchase 1 | Type of preparation | Water (g/100 g) | Nitrogen (g/100 g) | Total Protein 2 (g/100 g) | Sugars 3 (g/100 g) | HEW proteinsother than LSZ 4 (+/−) |
|---|---|---|---|---|---|---|---|
| 1 | Netherland (M) | Granular | 5.00 | 17.38 | 91.9 | n.d. | + |
| 2 | Italy (D) | Granular |
| 16.73 | 88.5 | n.d. | + |
| 3 | Italy (D) | Granular |
| 16.75 | 88.6 | n.d. | - |
| 4 | Germany (M) | Powder |
|
| 87.2 | 0 | +++ |
| 5 | Italy (D) | Granular |
| 16.81 | 88.9 | n.d. | + |
| 6 | Italy (D) | Powder | 5.07 |
| 82.9 | 7.6 (g) | +++ |
| 7 | Italy (M) | Granular |
| 16.86 | 89.2 | n.d. | + |
| 8 | Italy (D) | Granular | 5.10 | 16.77 | 88.7 | n.d. | ++ |
| 9 | Switzerland (M) | Granular | 5.70 | 17.20 | 91.0 | n.d. | - |
| 10 | Italy (D) | Granular | 5.00 | 17.44 | 92.3 | n.d. | ++ |
| 11 | Germany (D) | Powder |
| 16.84 | 89.1 | n.d. | + |
| 12 | Spain (D) | Granular |
|
| 66.3 | 24.0 (g) | - |
| 13 | Spain (D) | Liquid 5 | n.d. | 4.15 | 22.0 | n.d. | + |
| 14 | Spain (D) | Granular | 5.50 |
| 70.4 | 17.3 (s) | ++ |
| 15 | Belgium (M) | Powder | 4.10 | 17.14 | 90.7 | n.d. | + |
| 16 | Canada (M) | Granular | 5.40 | 17.31 | 91.6 | n.d. | + |
| 17 | Poland (M) | Powder | 5.00 |
| 85.2 | 0 | ++++ |
1 (M): manufacturer or (D): distributor; 2 By calculation (N × 5.29); 3 (g): glucose; (s): starch and trace levels of maltose, maltotriose and glucose; 4 As visually evaluated from SDS-PAGE gels; n.d.: not determined; 5 Values are expressed as g/100 mL.
Potency (microbiological activity) and concentration (HPLC) of lysozyme in the commercial preparations.
| Sample | Type of preparation | Anhydrous basis (mg/g) | Product basis 1 (g/100 g product) | Protein basis (g/100 g protein) | |||
|---|---|---|---|---|---|---|---|
| Potency | Potency | Concentration | Potency | Concentration | |||
| 1 | Granular | 1008 | 96 ± 1.73 | 100 ± 0.71 | 104 | 109 | |
| 2 | Granular | 929 | 87 ± 0.06 | 83 ± 0.70 | 98 | 94 | |
| 3 | Granular | 1040 | 97 ± 1.58 | 97 ± 2.11 | 110 | 109 | |
| 4 | Powder | 872 | 81 ± 0.13 | 75 ± 0.70 | 92 | 86 | |
| 5 | Granular | 968 | 91 ± 0.46 | 86 ± 1.68 | 102 | 96 | |
| 6 | Powder | 753 | 71 ± 0.51 | 66 ± 1.95 | 86 | 80 | |
| 7 | Granular | 949 | 87 ± 0.17 | 80 ± 1.36 | 97 | 90 | |
| 8 | Granular | 985 | 93 ± 0.23 | 95 ± 4.28 | 105 | 107 | |
| 9 | Granular | 1027 | 97 ± 0.02 | 99 ± 2.10 | 106 | 109 | |
| 10 | Granular | 1001 | 95 ± 0.41 | 95 ± 1.42 | 103 | 103 | |
| 11 | Powder | 960 | 88 ± 0.32 | 79 ± 2.13 | 99 | 89 | |
| 12 | Granular | 747 | 70 ± 2.90 | 76 ± 0.69 | 105 | 114 | |
| 13 2 | Liquid | n.d. | 26 ± 0.56 | 24 ± 1.41 3 | 118 | 108 3 | |
| 14 | Granular | 746 | 70 ± 1.13 | 70 ± 0.70 | 100 | 99 | |
| 15 | Powder | 985 | 94 ± 0.07 | 84 ± 0.71 | 104 | 93 | |
| 16 | Granular | 1025 | 97 ± 1.40 | 93 ± 2.11 | 106 | 101 | |
| 17 | Powder | 643 | 61 ± 0.24 | 52 ± 0.72 | 72 | 61 | |
1 Mean values ± relative standard deviation; 2 Values on product basis are expressed as g/100 mL; 3 Area of the two main peaks was considered (see paragraph 2.2); n.d.: not determined.
Figure 1Sodium dodecyl sulphate (SDS) gel electrophoresis of commercial lysozyme preparations. Lane M: molecular weight markers; Lane from 1 to 17: lysozyme samples; F: FIP lysozyme standard; S: Sigma-Aldrich lysozyme; L: lysozyme; A: avidin; Ot: ovotransferrin; Oa: ovalbumin; G: gallin; Om: ovomucoid.
Figure 2Correlation between potency (microbiological activity) and concentration (HPLC) of lysozyme in commercial preparations.
Figure 3HPLC patterns of lysozyme in commercial preparations nr 13 (pattern a) and nr 15 (pattern b) and in lysozyme standard (pattern c).